Mylan

991 articles about Mylan

• Mylan Inc. Pre-Pays $196 Million in Debt Due in 2011

  1/8/2010

• Mylan Inc. Seeks Approval of Generic of Merck & Co., Inc.'s Vytorin; Expects 180 Days Exclusivity on Generic

  12/22/2009

• Mylan Inc. Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories Limited' New Drug Application (NDA) for Efavirenz Tablets

  12/22/2009

• Mylan Inc. Added to The Nasdaq Stock Market -- New York-100 Index

  12/14/2009

• Mylan Inc. Announces Settlement Agreement Related to Antidepressant Effexor XR(R)

  12/8/2009

• Mylan Inc. Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories Limited

  11/11/2009

• Mylan Inc. Posts Net Loss, But Results Top Street View

  10/29/2009

• Mylan Inc. Declares Quarterly Preferred Stock Dividend

  10/20/2009

• Teva Pharmaceutical Industries Limited Sues Mylan Inc. Alleging Copaxone Patent Infringement

  10/19/2009

• Mylan Inc. Resolves Longstanding Dispute with DOJ Regarding Certain Medicaid Rebate Classifications from 2000 Through 2004

  10/19/2009

• Mylan Inc. Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast

  10/15/2009

• Mylan Inc. Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules

  10/15/2009

• Mylan Inc. Announces Settlement Agreement Related to Vfend(R) First-to-File Opportunity

  10/14/2009

• Pharma Giants On Look-out For Cure Against 'No Frills Drugs'; GlaxoSmithKline, Bayer AG, AstraZeneca AB. And Novartis AG Meet to Discuss Pharmaceutical Futures

  10/1/2009

• Mylan Inc. Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R)

  9/30/2009

• FDA Warns Consumers Not to Use Stolen Dey, L.P. Albuterol Sulfate Inhalation Solution and Ipratropium Bromide Inhalation Solution

  9/18/2009

• Mylan Inc.'s Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets

  9/16/2009

• U.S. FDA to Review Mylan Inc.'s Generic Copaxone

  9/14/2009

• Mylan Inc. Says Parting Ways with Recently Hired CFO

  9/9/2009

• Mylan Inc. Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment

  8/27/2009